Accéder au contenu
Merck

Effects of in vitro and in vivo avermectin exposure on alpha synuclein expression and proteasomal activity in pigeons.

Ecotoxicology and environmental safety (2016-09-28)
Ming Li, Shuo Zhou, Xian-Song Wang, Ci Liu, Shu Li
RÉSUMÉ

Avermectins (AVMs) are used worldwide in agriculture and veterinary medicine. Residues of avermectin drugs, causing toxicological effects on non-target organisms, have raised great concern. The aim of this study was to investigate the effects of AVM on the expression levels of alpha synuclein (α-Syn) and proteasomal activity in pigeon (Columba livia) neurons both in vivo and in vitro. The results showed that, the mRNA and protein levels of α-Syn increased in AVM treated groups relative to control groups in the cerebrum, cerebellum and optic lobe in vivo. Dose-dependent decreases in the proteasomal activity (i.e., chymotrypsin-like, trypsin-like and peptidylglutamyl peptidehydrolase) were observed both in vivo and in vitro. The results suggested that AVM could induce the expression levels of α-Syn and inhibit the normal physiological function of proteasome in brain tissues and neurons. The information presented in this study is helpful to understand the mechanism of AVM-induced neurotoxicology in birds.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Ala-Ala-Phe-7-amido-4-methylcoumarin, protease substrate
Sigma-Aldrich
Boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin, protein C substrate